Intellectual Property

Apex AI is committed to pioneering AI-driven gastrointestinal cancer diagnostics through continuous research and development. Our intellectual property portfolio includes multiple patents and software copyrights, solidifying our leadership in AI-powered medical imaging and predictive diagnostics.

Patents & Intellectual Property Filings

No.

Patent Holder

Country

Status

Patent Number

Title / Description

1

Apex AI

South Korea

Filed

10-2020-0003735

Graph Model-Based AI System for Log Analysis & Batch Scheduling

2

Apex AI

South Korea

Filed

10-2020-0052393

AI-Based Stomach Endoscopy Image Analysis for Cancer Risk Prediction

3

Apex AI

South Korea

Filed

10-2021-0025707

AI-Based Colonoscopy Image Analysis for Colorectal Cancer Risk Prediction

4

Apex AI

South Korea

Filed

10-2021-0025708

AI-Based Gastrointestinal Endoscopy Analysis for Cancer Risk Prediction

5

Apex AI

South Korea

Filed

10-2021-0025709

AI-Based Small Intestine Endoscopy Analysis for Abnormality Detection

6

Apex AI

South Korea

Filed

10-2021-0025710

AI-Based Temporal Medical Image Data Analysis for Disease Onset Prediction

7

Apex AI

South Korea

Filed

10-2021-0026094

Feedback-Based AI Machine Learning Optimization System

8

Apex AI

South Korea

Filed

10-2023-0113554

AI-Based Predictive Model for Disease Onset Using Temporal Medical Data

9

Apex AI

South Korea

Filed

10-2023-0113555

AI-Based Stepwise Learning System for Efficient Machine Learning


Software Copyrights & Certifications

Category

Certified By

Certification Number

Description

Software Copyright

Korea Copyright Commission

C-2020-014150

AI Stomach Cancer Prediction Program (AI-powered risk assessment & predictive modeling for gastric cancer)

Last updated